Biopharma Insights - page 11

ThermoFace: Revealing Biological Age and Hidden Health Risks via Your Face's Heat Map

In a groundbreaking study published in Cell Metabolism in July 2024, researchers introduced "ThermoFace," a mew method that utilizes thermal facial imaging to assess biological age and predict the presence …

Continue ›››

How to Achieve Successful Digital Transformation in Healthcare

The NHS is under unprecedented strain, with wait and referral times reaching record highs and a £749 million overspend leading to a budget deficit across trusts in the UK. Despite …

Continue ›››

How to Define Intelligence and Consciousness for In Silico and Organoid-based Systems?

A global initiative is underway to create consensus definitions for diverse intelligent systems, including AI, LLMs, and biological intelligences. Led by Cortical Labs, the biological computing startup known for "Dishbrain," …

Continue ›››

Off-the-Shelf Stem Cell Therapy Reduces Pain by 58%, Regenerates Cartilage

A clinical trial of a novel off-the-shelf stem cell therapy for knee osteoarthritis has shown significant improvements in pain relief and joint function, offering hope for patients suffering from this …

Continue ›››

Biotech Trends to Watch: Reflecting on the First Half of 2024

If we talk about tech advances in pharma and biotech, the year 2024 has been a blast so far! Last December I compiled a list of 11 Biopharma Trends to …

Continue ›››

10 Notable Biotech Companies With Recent Major VC Rounds

As the biotech sector recovers to pre-COVID investment levels, venture capital firms have become more selective in their funding choices. In 2024, private U.S. drug companies raised $3.8 billion in …

Continue ›››

Beyond Neuralink: The Diverse Landscape of Brain-Computer Interfaces

Brain-Computer Interfaces (BCIs) have captured the public imagination, largely due to high-profile projects like Neuralink from Elon Musk's, who revealed planned improvements to their modus operandi. However, the BCI landscape …

Continue ›››

A Growing Race to Change Status Quo in the Lucrative NGS Market

Element Biosciences has raised over $277 million in a Series D funding round to further develop and commercialize its DNA sequencing and multi-omics technologies. The oversubscribed round was led by …

Continue ›››

A Booming Anti-Obesity Drug Discovery Landscape at a Glance (With Challenges)

In 1986, Danish scientist Jens Juul Holst discovered that the gut hormone GLP-1 stimulates insulin and suppresses appetite. This research led to the development of two blockbuster weight-loss drugs: Wegovy …

Continue ›››

This Company Anonymized 1.8 Trillion Records to Support Biomedical Research

In the rapidly evolving life sciences and healthcare landscape, the secure and privacy-preserving exchange and linkage of health data is paramount. The topic of biomedical data collection and processing received …

Continue ›››

85% of Healthcare Leaders Investing or Plan to Invest in Gen AI, According to the Largest Survey

Among many important helathcare tech topics discussed at the inagural HLTH Europe 2024 conference taking place on June 17-20 in Amsterdam, generative artificial intelligence (AI) has seemingly taken the central …

Continue ›››

The Rise of Cyclic Peptides: Bridging the Gap in Modern Medicine

Cyclic peptides, characterized by their unique ring structures, represent an emerging trend in drug discovery due to their ability to bridge the gap between small molecules and biologics.

Continue ›››